HMGB1 as a DNA-binding cytokine

Journal of Leukocyte Biology

Volumn 72, Issue 6, 2002, Pages 1084-1091

  Andersson, Ulf ^a   Erlandsson Harris, Helena ^a   Yang, Huan ^b   Tracey, Kevin J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Astrid Lindgren Children's Hospital ^*  (United States)

Author keywords

Arthritis; Inflammation; Necrosis; Nuclear cytokine; RAGE ligand; Sepsis

Indexed keywords

CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN;

ARTHRITIS; BACTERICIDAL ACTIVITY; CHEMOTAXIS; CYTOKINE PRODUCTION; DNA BINDING; DNA SEQUENCE; EPITHELIUM CELL; INFLAMMATION; MACROPHAGE ACTIVATION; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SEPSIS;

ANIMALS; CYTOKINES; DNA-BINDING PROTEINS; HMGB1 PROTEIN; HUMANS; INFLAMMATION;

EID: 0036908921     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Goodwin, G. H., Sanders, C., Johns, E. W. (1973) A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem. 38, 14-17.
2. Bustin, M. (1999) Regulation of DNA-dependent activities by the functional motifs of the high mobility group chromosomal proteins. Mol. Cell. Biol. 19, 5237-5246.
3. Bianchi, M. E., Beltrame, M. (2000) Upwardly mobile proteins. The role of HMG proteins in chromatine structure, gene expression and neoplasia. EMBO Rep. 1, 109-119.
4. Bustin, M. (2001) Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem. Sci. 26, 152-153.
5. Read, C. M., Cary, P. D., Crane-Robinson, C., Driscoll, P. C., Norman, D. G. (1993) Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Res. 21, 3427-3436.
6. Weir, H. M., Kraulis, P. J., Hill, C. S., Raine, A. R. C., Laue, E. D., Thomas, J. O. (1993) Structure of the HMG box motif in the B-domain of HMG1. EMBO J. 12, 1311-1319.
7. Hardman, C. H., Broadhurst, R. W., Raine, A. R. C., Grasser, K. D., Thomas, J. O., Laue, E. D. (1995) Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three- and four-dimensional NMR spectroscopy. Biochemistry, 34, 16596-16607.
8. Merenmies, J., Pihlaskari, R., Laitinen, J., Wartiovaara, J., Rauvala, H. (1991) 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J. Biol. Chem. 266, 16722-16729.
9. Ronfani, R., Ferraguti, M., Croci, L., Ovitt, C. E., Schöler, H. R., Consalez, G. G., Bianchi, M. E. (2001) Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2. Development 128, 1265-1273.
10. Vaccari, T., Beltrame, M., Ferrari, S., Bianchi, M. E. (1998) Hnzg4, a new member of the Hmg 1/2 gene family. Genomics 49, 247-252.
11. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K. R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P. E., Abumrad, N. N., Sama, A., Tracey, K. J. (1999) HMG1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251.
12. Wang, H., Vishnubhakat, J. M., Bloom, O., Zhang, M., Ombrellino, M., Sama, A., Tracey, K. J. (1999) Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126, 389-392.
13. Andersson, U., Wang, H., Palmblad, K., Aveberger, A-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Yang, H., Tracey, K. J. (2000) HMG1 stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192, 565-570.
14. Paonessa, G., Frank, R., Cortese, R. (1987) Nucleotide sequence of rat liver HMG1 cDNA. Nucleic Acids Res. 15, 9077-9081.
15. Wen, L., Huang, J. K., Johnson, B. H., Reeck, G. R. (1989) A human placental cDNA clone that encodes nonhistone chromosomal protein HMG1. Nucleic Acids Res. 17, 1197-1214.
16. Rauvala, H., Merenmies, J., Pihlaskari, R., Korkolainen, M., Huhtala, M-L., Panula, P. (1988) The adhesive and neurite-promoting molecule p30: Analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons. J. Cell Biol. 107, 2293-2305.
17. Ferrari, S., Finelli, P., Rocchi, M., Bianchi, M. E. (1996) The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. Genomics 35, 367-371.
18. Calogero, S., Grassi, F., Aguzzi, A., Voigtlander, T., Ferrier, P., Ferrari, S., Bianchi, M. E. (1999) The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycemia in newborn mice. Nat. Genet. 22, 276-280.
19. Ombrellino, M., Wang, H., Ajemian, M. S., Talhouk, A., Scher, L. A., Friedman, S. G., Tracey, K. J. (1999) Increased serum concentrations of high-mobility-group protein 1 in hemorrhagic shock. Lancet 354, 1446-1447.
20. Abraham, E., Arcaroli, J., Carmody, A., Wang, H., Tracey, K. J. (2000) HMG1 as a mediator of acute lung injury. J. Immunol. 165, 2950-2954.
21. Yang, H., Wang, H., Tracey, K. J. (2001) HMG1 rediscovered as a cytokine. Shock 15, 247-253.
22. Galanos, C., Freudenberg, M. A., Reutter, W. (1979) Galactosamine-induced sensitization of the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76, 5939-5943.
23. Lehmann, V., Freudenberg, M. A., Galanos, C. (1987) Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamin-treated mice. J. Exp. Med. 165, 657-663.
24. Morikawa, A., Sugijama, T., Kato, Y., Koide, N., Jiang, G. Z., Takahashi, K., Tamada, Y., Yokochi, T. (1996) Apoptotic cell death in the response of D-galactosamin-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. Infect. Immun. 64, 734-738.
25. Hishinuma, I., Nagakawa, J., Hirota, K., Miyamoto, K., Tsukidate, K., Yamanaka, T., Katayama, K., Yamatsu, I. (1990) Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology 12, 1187-1191.
26. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D. (1986) Shock and tissue injury induced by recombinant human cachectin. (1986) Science 234, 470-474.
27. Wichmann, M. W., Haisken, J. M., Ayala, A., Chaudry, I. H. (1996) Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge. J. Surg. Res. 65, 109-114.
28. Rauvala, H., Huttunen, H. J., Fages, C., Kaksonen, M., Kinnunen, T., Imai, S., Raulo, E., Kilpelainen, I. (2000) Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol. 19, 377-387.
29. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761.
30. Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., Hofmann, M. A., Kislinger, T., Ingram, M., Lu, A., Tanaka, H., Hori, O., Ogawa, S., Stern, D. M., Schmidt, A. M. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405, 354-360.
31. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998-15004.
32. Schmidt, A. M., Yan, S. D., Yan, S. F., Stern, D. M. (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochem. Biophys. Acta 1498, 99-111.
33. Huttunen, H. J., Fages, C., Rauvala, H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924.
34. Miyata, T., Hori, O., Zhang, J., Yan, S. D., Ferran, L., Iida, Y., Schmidt, A. M. (1996) The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J. Clin. Invest. 98, 1088-1094.
35. Degryse, B., Bonaldi, T., Scaffidi, P., Muller, S., Resnati, M., Sanvito, F., Arrigoni, G., Bianchi, M. E. (2001) The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152, 1197-1206.
36. Sparatore, B., Pedrazzi, M., Passalacqua, M., Gaggero, D., Patrone, M., Pentremoli, S., Melloni, E. (2002) Stimulation of erythroleukaemia cell differentiation by extracellyular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products. Biochem. J. 363, 529-535.
37. Bianchi, M. E. (1988) Interaction of a protein from rat liver nuclei with cruciform DNA. EMBO J. 7, 843-849.
38. Salmivirta, M., Rauvala, H., Elenius, K., Jalkanen, M. (1992) Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp. Cell Res. 200, 444-451.
39. Muller, S., Scaffidi, P., Deglyse, B., Bonaldi, T., Ronfani, L., Agresti, A., Beltrame, M., Bianchi, M. E. (2001) New EMBO members' review: The double life of HMGB1 chromatin protein: Architectural factor and extracellular signal. EMBO J. 16, 4337-4340.
40. Scaffidi, P., Misteli, T., Bianchi, M. E. (2002) The release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195.
41. Falciola, L., Spada, F., Calogero, S., Längst, G., Voit, R., Grummt, I., Bianchi, M. E. (1997) High mobility group 1 (HMG1) protein is not stably associated with the chromosomes of somatic cells. J. Cell Biol. 137, 19-26.
42. Spada, F., Brunet, A., Mercier, Y., Renard, J. P., Bianchi, M. E., Thompson, E. M. (1998) High mobility group 1 (HMG1) protein in mouse preimplantation embryos. Mech. Dev. 76, 57-66.
43. Li, M., Carpio, D. F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, M. R., Beg, A. A. (2001) An essential role of the NF-κB/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166, 7128-7135.
44. Medzhitov, R. (2001) Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145.
45. Zetterström, C. K., Bergman, T., Rynnel-Dagöö, B., Erlandsson-Harris, H., Söder, O., Andersson, U., Boman, H. G. (2002) High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid. Pediatr. Res. 52, 148-154.
46. Rouhiainen, A., Imai, S., Rauvala, H., Parkkinen, J. (2000) Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb. Haemost. 84, 1087-1094.
47. Parkkinen, J., Rauvala, H. (1991) Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J. Biol. Chem. 266, 16730-16735.
48. Parkkinen, J., Raulo, E., Merenmies, J., Nolo, R., Kajander, E. O., Baumann, M., Rauvala, H. (1993) Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J. Biol. Chem. 268, 19726-19738.
49. Gardella S., Andrei, C., Ferrera D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E., Rubartelli, A. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory, pathway. EMBO Rep. 3, 995-1001.
50. Kokkola, R., Sundberg, E., Ulfgren, A.-K., Palmblad, K., Li, J., Wang, H., Ulloa, L., Yang, H., Yan, X.-J., Furie, R., Chiorazzi, N., Tracey, K. J. Andersson, U., Erlandsson-Harris, H. High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis. Arthritis Rheum. 46, 2598-2603.